Loomis Sayles & CO L P Bristol Myers Squibb CO Transaction History

Loomis Sayles & CO L P

$76.2 Billion
Q3 2024

A detailed history of Loomis Sayles & CO L P transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Loomis Sayles & CO L P holds 277,599 shares of BMY stock, worth $16.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

277,599

Previous 214,997 29.12%

Holding current value

$16.3 Million

Previous $8.93 Million 60.86%

% of portfolio

0.02%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$39.66 - $51.75 $2.48 Million - $3.24 Million	62,602 Added 29.12%	277,599 $14.4 Million
Q2 2024 Aug 13, 2024	BUY	$40.25 - $52.99 $2.75 Million - $3.62 Million	68,277 Added 46.54%	214,997 $8.93 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $1.96 Million - $2.22 Million	40,778 Added 38.49%	146,720 $7.96 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $2.4 Million - $2.86 Million	49,458 Added 87.56%	105,942 $5.44 Million
Q3 2023 Nov 09, 2023	SELL	$57.89 - $64.73 $294,486 - $329,281	-5,087 Reduced 8.26%	56,484 $3.28 Million
Q2 2023 Aug 11, 2023	BUY	$63.71 - $70.74 $950,489 - $1.06 Million	14,919 Added 31.98%	61,571 $3.94 Million
Q1 2023 May 11, 2023	SELL	$65.71 - $74.53 $536,916 - $608,984	-8,171 Reduced 14.9%	46,652 $3.23 Million
Q4 2022 Feb 10, 2023	BUY	$68.48 - $81.09 $368,285 - $436,102	5,378 Added 10.88%	54,823 $3.95 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $26,417 - $15.6 Million	-203,215 Reduced 80.43%	49,445 $3.52 Million
Q2 2022 Aug 05, 2022	SELL	$72.62 - $79.98 $11.4 Million - $12.5 Million	-156,371 Reduced 38.23%	252,660 $19.5 Million
Q1 2022 May 13, 2022	SELL	$61.48 - $73.72 $10.5 Million - $12.6 Million	-171,403 Reduced 29.53%	409,031 $29.9 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $761,760 - $888,034	14,204 Added 2.51%	580,434 $36.2 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $77.5 Million - $90.8 Million	-1,310,346 Reduced 69.83%	566,230 $33.5 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $211 Million - $230 Million	-3,409,763 Reduced 64.5%	1,876,576 $125 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $367 Million - $412 Million	-6,177,770 Reduced 53.89%	5,286,339 $334 Million
Q4 2020 Feb 12, 2021	SELL	$57.74 - $65.43 $111 Million - $126 Million	-1,922,942 Reduced 14.36%	11,464,109 $711 Million
Q3 2020 Nov 12, 2020	SELL	$57.43 - $63.64 $10.9 Million - $12.1 Million	-189,768 Reduced 1.4%	13,387,051 $807 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $668,091 - $781,064	-12,187 Reduced 0.09%	13,576,819 $798 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $7.8 Million - $11.3 Million	-168,113 Reduced 1.22%	13,589,006 $757 Million
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $28.9 Million - $37.6 Million	-586,460 Reduced 4.09%	13,757,119 $883 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $967,243 - $1.15 Million	22,615 Added 0.16%	14,343,579 $727 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $82.6 Million - $91.3 Million	1,850,195 Added 14.84%	14,320,964 $649 Million
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $74 Million - $88.2 Million	1,639,468 Added 15.14%	12,470,769 $595 Million
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $41.8 Million - $54.2 Million	856,802 Added 8.59%	10,831,301 $563 Million
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $189 Million - $213 Million	-3,428,625 Reduced 25.58%	9,974,499 $619 Million
Q2 2018 Aug 14, 2018	SELL	$50.53 - $62.98 $3.24 Million - $4.04 Million	-64,206 Reduced 0.48%	13,403,124 $742 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $2.77 Million - $3.19 Million	-46,287 Reduced 0.34%	13,467,330 $852 Million
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $4.46 Million - $4.86 Million	-74,440 Reduced 0.55%	13,513,617 $828 Million
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $20.4 Million - $23.6 Million	369,832 Added 2.8%	13,588,057 $866 Million
Q2 2017 Aug 14, 2017	BUY	N/A	13,218,225	13,218,225 $737 Million

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Loomis Sayles & CO L P, based on Form 13F filings with the SEC.

News

Stay updated on Loomis Sayles & CO L P with notifications on news.

Account

Loomis Sayles & CO L P Bristol Myers Squibb CO Transaction History